Gossamer Bio, Inc. (GOSS)
0.4309
+0.01
(+1.41%)
USD |
NASDAQ |
Mar 02, 15:21
Gossamer Bio EPS Diluted (Quarterly) : -0.2115 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -2.389 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| XOMA Royalty Corp. | 0.6991 |
| Rezolute, Inc. | -0.2196 |
| Axsome Therapeutics, Inc. | -0.5641 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.22M |
| Revenue (Quarterly) | 13.29M |
| Total Expenses (Quarterly) | 61.52M |
| Enterprise Value | 121.00M |
| Gross Profit Margin (Quarterly) | 98.35% |
| Profit Margin (Quarterly) | -362.7% |
| Earnings Yield | -159.5% |
| Normalized Earnings Yield | -154.14 |